Navigation Links
Kimberly-Clark Acquires Baylis Medical Company's Pain Management Business
Date:10/5/2009

DALLAS, Oct. 5 /PRNewswire-FirstCall/ -- Kimberly-Clark Corporation (NYSE: KMB) announced today that it has acquired Baylis Medical Company's pain management business, which includes a number of innovative, minimally-invasive radio-frequency pain management products. Kimberly-Clark's Health Care business has been the exclusive distributor of Baylis Medical's pain management products in the U.S. since 2001.

The acquisition improves the competitive position of Kimberly-Clark Health Care in the $2 billion global market for minimally invasive chronic spinal pain management. Financial terms of the transaction were not disclosed.

"The acquisition of Baylis Medical's pain management business is consistent with our global business plan strategy to invest in the higher-growth, higher-margin medical device market," said Joanne Bauer, president, Kimberly-Clark Health Care. "This transaction will enable us to accelerate the growth of our pain management business around the world while strengthening our commitment to patients suffering from chronic spinal pain. Together with Baylis Medical, we're enhancing patients' quality of life through minimally invasive, radio-frequency therapies."

Baylis Medical President Frank Baylis said that today's announcement is a logical move for both companies. "We are very excited about Kimberly-Clark's acquisition of Baylis Medical's pain management business. We've enjoyed an excellent and mutually beneficial working relationship over the last eight years and integrating our technology with Kimberly-Clark's global resources makes for a unique and powerful offering in the pain management category," he said.

About Kimberly-Clark and Kimberly-Clark Health Care

Kimberly-Clark and its well-known global brands are an indispensable part of life for people in more than 150 countries. To learn more about Kimberly-Clark and its 137-year history of innovation, visit www.kimberly-clark.com.

Around the world, medical professionals turn to Kimberly-Clark for a wide portfolio of solutions that improve the health, hygiene and well-being of their patients and staff. As part of their healing mission, caregivers rely on Kimberly-Clark Health Care to deliver clinical solutions and educational resources that they can depend on to prevent, diagnose and manage a wide variety of healthcare-associated infections. This over $1 billion global enterprise of Kimberly-Clark Corporation holds the No. 1 and No. 2 market share positions in several categories including infection control solutions, surgical solutions, pain management and digestive health. And throughout the care continuum, patients and staff alike trust Kimberly-Clark* medical supplies and devices, Kleenex tissues, Kimberly-Clark* professional skin care products, and Scott towels for day-to-day needs. For more information, please visit http://www.kchealthcare.com.

About Baylis Medical Company

Baylis is a leading developer, manufacturer and supplier of high-technology medical devices for chronic pain management, interventional cardiology, and radiology. Founded in 1986 in Montreal, Quebec, Baylis has grown to have offices across Canada as well as in the United Kingdom and Asia. The company's research, development and manufacturing departments are located in Mississauga, Ontario. Baylis presently employs over 130 staff and markets its products in over 60 countries. Baylis Medical's vision is to bring to market state-of-the-art medical products that will improve the lives of people around the world.

Certain matters contained in this news release concerning the business outlook, including expected savings, anticipated financial and operating results, strategies, contingencies and anticipated transactions of the company constitute forward-looking statements and are based upon management's expectations and beliefs concerning future events impacting the company. There can be no assurance that these future events will occur as anticipated or that the company's results will be as estimated. For a description of certain factors that could cause the company's future results to differ materially from those expressed in any such forward-looking statements, see Item 1A of the company's Annual Report on Form 10-K for the year ended December 31, 2008 entitled "Risk Factors."

SOURCE Kimberly-Clark Corporation


'/>"/>
SOURCE Kimberly-Clark Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Bausch & Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux
2. Wound Management Technologies Acquires Resorbable Orthopedics
3. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim and Manufacturing Facility From PLIVA
4. Hospira Acquires Worldwide Rights to Biogeneric Version of Filgrastim
5. Prescient Medical, Inc. Acquires New Technology to Detect Inflammation in Coronary Blood Vessels
6. Nastech Reacquires Teriparatide (Parathyroid Hormone; PTH1-34) Nasal Spray from Procter & Gamble
7. MacroChem Acquires Rights to Pexiganan, a Novel Topical Anti-Infective for Treatment of Diabetic Foot Infections, From Genaera
8. U.S. Preventive Medicine Acquires Specialty Disease Management
9. Image Solutions, Inc. Acquires Zurich Biostatistics, Inc.
10. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
11. Misonix, Inc. Announces the Sale of Sonora Medical Systems for $8 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/17/2017)... Feb. 17, 2017 Arvinas LLC, a private ... on protein degradation, today announced the presentation of new ... during a poster session at the American Society of ... Orlando, FL. ... platform and the potential of PROTACs to drive durable ...
(Date:2/17/2017)... --  Risperdal lawsuits involving gynecomastia (male breast growth) ... the atypical antipsychotic medication continue to move forward in ... Pleas, where the state,s Risperdal docket has been centralized ... posted on the Court,s website , the litigation ... 2017 at 11:00 a.m. (In Re: Risperdal Litigation, Case ...
(Date:2/17/2017)... 2017 On Thursday, February 16, ... lower at the closing bell, while the Dow Jones ... benchmark. Moreover, five out of nine sectors ended Thursday,s ... market sentiment, Stock-Callers.com assessed the following Medical Appliances & ... SNN ), ABIOMED Inc. (NASDAQ: ...
Breaking Medicine Technology:
(Date:2/17/2017)... ... February 17, 2017 , ... While ... Enovate Medical has introduced an innovative workstation designed to reduce nursing fatigue while ... Encore Mobile EHR Workstation offers a lightweight, highly mobile, multi-functional alternative to the ...
(Date:2/17/2017)... ... February 17, 2017 , ... Empowering each person's mental functions, ... each and every seminar, session and class she offers. At the International ... which help energize creativity, focus mental functions, enhance athletic focus and skill sets, ...
(Date:2/17/2017)... Tx (PRWEB) , ... February 17, 2017 , ... ... revenue cycle management services, announced today that Karen Pilley has been promoted to ... is critical in today’s shifting healthcare paradigm – a shift that demands the ...
(Date:2/17/2017)... BEAVER CREEK, CO (PRWEB) , ... February 17, 2017 , ... ... the second annual International Healing NET Foundation Summit from February 21 - 23 in ... Healing NET Foundation (HNF). This marks the Summit’s second year in Beaver Creek, hosting ...
(Date:2/16/2017)... DC (PRWEB) , ... February 17, 2017 , ... Teaching ... Excellence (ACE) program, now in development. ACE.P (pediatrics) is being created with the support ... the Care of Vulnerable Populations , ACE.P will address what has been identified as ...
Breaking Medicine News(10 mins):